Showing results (91-100 of 252) with videos related to

Sort By:
Pageof 26
Journal of Hepatology|August 21, 2023
Progression of non-alcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort studyTracey G Simon, Bjorn Roelstraete, Hannes Hagström, et al.
European Heart Journal. Case Reports|March 5, 2020
Lomitapide treatment in a female with homozygous familial hypercholesterolaemia: a case reportKarin Littmann, Karolina Szummer, Hannes Hagström, et al.
Scandinavian Journal of Gastroenterology|June 18, 2025
HCC-surveillance is associated with improved HCC-related mortality in patients with cirrhosis - a case-control studyHannes Hegmar, Bonnie Bengtsson, Sofia Ullman, et al.
The Lancet Regional Health. Europe|August 14, 2025
Socioeconomic disparities in incidence, treatment, and survival of intrahepatic cholangiocarcinoma: insights from a nationwide cohort study in SwedenJuan Vaz, Hannes Hagström, Per Sandström, et al.
United European Gastroenterology Journal|May 2, 2022
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population-based cohort studyBonnie Bengtsson, Linnea Widman, Staffan Wahlin, et al.
Open Heart|June 28, 2019
Peripheral artery disease and outcomes in patients with acute myocardial infarctionRubina Attar, Axel Wester, Sasha Koul, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 16, 2020
Increased Mortality Risk in Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With HistopathologyRajani Sharma, Elizabeth C Verna, Jonas Söderling, et al.
Scandinavian Journal of Gastroenterology|September 13, 2016
SAF score and mortality in NAFLD after up to 41 years of follow-upHannes Hagström, Patrik Nasr, Mattias Ekstedt, et al.
Scientific Reports|November 28, 2022
Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver diseaseMagnus Holmer, Hannes Hagström, Ping Chen, et al.
Alimentary Pharmacology & Therapeutics|December 25, 2022
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkersHannes Hagström, Jacinth Yan, Mats Talbäck, et al.
Pageof 26